Wegovy Bundle - 3x Pens (0.25, 0.5 & 1mg)

Wegovy is typically administered through a subcutaneous injection, meaning it's injected under the skin, usually once a week at the same time for consistency. The injection can be given in the abdomen, thigh, or upper arm, and the dosage varies depending on individual factors such as weight and response to treatment, determined by your assigned prescriber. Wegovy is to be used alongside a reduced-calorie diet and increased physical activity as directed by clinical prescriber for optimal results.

The main ingredient in Wegovy is semaglutide. Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. This means it mimics the action of natural hormones that regulate appetite and food intake in the body. GLP-1 receptor agonists work by reducing hunger and increasing feelings of fullness, leading to decreased food intake and, consequently, weight loss. Semaglutide is administered via injection and is designed to be used alongside a reduced-calorie diet and increased physical activity for the management of obesity or overweight in adults with certain weight-related medical conditions.

Some common side effects of Wegovy (semaglutide) may include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation. Additionally, other potential side effects may include abdominal pain, decreased appetite, fatigue, dizziness, and headache. It's important to note that not all individuals may experience these side effects, and some may experience none at all.

Wegovy comes with several warnings that users should be aware of. Firstly, it has been associated with an increased risk of pancreatitis, so patients experiencing severe abdominal pain should seek medical attention. Additionally, there's a potential risk of thyroid tumors, particularly in those with a history of thyroid cancer or a genetic predisposition. Patients should also be cautious about hypoglycemia, as Wegovy may lower blood sugar levels. Kidney function should be monitored regularly, especially in individuals with pre-existing kidney disease. Injection site reactions are possible, and pregnant or breastfeeding women should consult healthcare providers before using Wegovy due to its unknown effects in these populations.